Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision

被引:23
作者
Aiken, Abigail R. A. [1 ]
Wells, Elisa S. [2 ]
Gomperts, Rebecca [3 ]
Scott, James G. [4 ]
机构
[1] Univ Texas Austin, LBJ Sch Publ Affairs, POB Y, Austin, TX 78712 USA
[2] Natl Womens Hlth Network, Plan C, Washington, DC USA
[3] Aid Access, Amsterdam, Netherlands
[4] Univ Texas Austin, McCombs Sch Business, Austin, TX 78712 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 331卷 / 18期
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
TELEMEDICINE; MISOPROSTOL; MIFEPRISTONE; PREGNANCY; SAFE;
D O I
10.1001/jama.2024.4266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ImportanceThe Supreme Court decision in Dobbs v Jackson Women's Health Organization overturned the right to choose abortion in the US, with at least 16 states subsequently implementing abortion bans or 6-week gestational limits. Prior research indicates that in the 6 months following Dobbs, approximately 32 360 fewer abortions were provided within the US formal health care setting. However, trends in the provision of medications for self-managed abortion outside the formal health care setting have not been studied. ObjectiveTo determine whether the provision of medications for self-managed abortion outside the formal health care setting increased in the 6 months after Dobbs. Design, Setting, and ParticipantsCross-sectional study using data from sources that provided abortion medications outside the formal health care setting to people in the US between March 1 and December 31, 2022, including online telemedicine organizations, community networks, and online vendors. Using a hierarchical bayesian model, we imputed missing values from sources not providing data. We estimated the change in provision of medications for self-managed abortion after the Dobbs decision. We then estimated actual use of these medications by accounting for the possibility that not all provided medications are used by recipients. ExposureAbortion restrictions following the Dobbs decision. Main Outcomes and MeasuresProvision and use of medications for a self-managed abortion. ResultsIn the 6-month post-Dobbs period (July 1 to December 31, 2022), the total number of provisions of medications for self-managed abortion increased by 27 838 (95% credible interval [CrI], 26 374-29 175) vs what would have been expected based on pre-Dobbs levels. Excluding imputed data changes the results only slightly (27 145; 95% CrI, 25 747-28 246). Accounting for nonuse of medications, actual self-managed medication abortions increased by an estimated 26 055 (95% CrI, 24 739-27 245) vs what would have been expected had the Dobbs decision not occurred. Conclusions and RelevanceProvision of medications for self-managed abortions increased in the 6 months following the Dobbs decision. Results suggest that a substantial number of abortion seekers accessed services despite the implementation of state-level bans and restrictions.
引用
收藏
页码:1558 / 1564
页数:7
相关论文
共 39 条
[1]   Advance Provision of Mifepristone and Misoprostol via Online Telemedicine in the US [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
van Blitterswijk, Danielle C. ;
Looijen, Carlijn ;
van Vliet, Thijs ;
Essink, Dirk R. ;
Gomperts, Rebecca .
JAMA INTERNAL MEDICINE, 2024, 184 (02) :220-223
[2]   Requests for Self-managed Medication Abortion Provided Using Online Telemedicine in 30 US States Before and After the Dobbs v Jackson Women's Health Organization Decision [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
Scott, James G. ;
Gomperts, Rebecca .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (17) :1768-1770
[3]   Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: A population based study [J].
Aiken, Abigail R. A. ;
Romanova, Evdokia P. ;
Morber, Julia R. ;
Gomperts, Rebecca .
LANCET REGIONAL HEALTH-AMERICAS, 2022, 10
[4]   Association of Texas Senate Bill 8 With Requests for Self-managed Medication Abortion [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
Scott, James G. ;
Gomperts, Rebecca .
JAMA NETWORK OPEN, 2022, 5 (02)
[5]   Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
Gomperts, Rebecca .
JAMA NETWORK OPEN, 2021, 4 (05)
[6]   Demand for Self-Managed Online Telemedicine Abortion in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
Gomperts, Rebecca ;
Tec, Mauricio ;
Scott, James G. ;
Aiken, Catherine E. .
OBSTETRICS AND GYNECOLOGY, 2020, 136 (04) :835-837
[7]   Demand for Self-Managed Medication Abortion Through an Online Telemedicine Service in the United States [J].
Aiken, Abigail R. A. ;
Starling, Jennifer E. ;
van der Wal, Alexandra ;
van der Vliet, Sascha ;
Broussard, Kathleen ;
Johnson, Dana M. ;
Padron, Elisa ;
Gomperts, Rebecca ;
Scott, James G. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2020, 110 (01) :90-97
[8]   Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland [J].
Aiken, Abigail R. A. ;
Digol, Irena ;
Trussell, James ;
Gomperts, Rebecca .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
[9]  
[Anonymous], 2023, #Wecount report April 2022 to June 2023, P2023, DOI DOI 10.46621/218569QKGMBL
[10]  
[Anonymous], 2022, NEW YORK TIMES 0503